HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Susan Moir Selected Research
Susan Moir Research Topics
Disease
23
Viremia
11/2019 - 04/2003
16
Infections
01/2022 - 06/2007
9
HIV Infections (HIV Infection)
01/2022 - 06/2007
7
Inflammation (Inflammations)
01/2021 - 09/2010
7
Human Influenza (Influenza)
01/2020 - 05/2005
4
COVID-19
04/2022 - 01/2021
3
Lymphopenia (Lymphocytopenia)
06/2009 - 02/2006
2
Autoimmune Diseases (Autoimmune Disease)
01/2021 - 01/2020
2
Neoplasms (Cancer)
01/2020 - 01/2017
2
Acquired Immunodeficiency Syndrome (AIDS)
01/2018 - 11/2016
2
Virus Diseases (Viral Diseases)
04/2017 - 01/2011
1
Superinfection
11/2021
1
Hyperplasia
01/2021
1
Malaria
01/2021
1
Acute malaria
01/2021
1
Macrophage Activation Syndrome
01/2020
1
Pulmonary Alveolar Proteinosis
01/2020
1
Dermatomyositis (Dermatopolymyositis)
01/2020
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2017
1
Persistent Infection
04/2017
1
Heart Diseases (Heart Disease)
01/2017
1
X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency)
01/2016
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2015
1
Chronic Disease (Chronic Diseases)
11/2015
1
Lipodystrophy
11/2015
1
Skin Diseases (Skin Disease)
11/2015
1
Lymphocytosis
01/2015
1
Epstein-Barr Virus Infections
01/2015
1
Coinfection
09/2014
1
Crohn Disease (Crohn's Disease)
06/2014
1
Type IIB Congenital Disorder Of Glycosylation
04/2014
1
Agammaglobulinemia (Hypogammaglobulinemia)
04/2014
1
Graves Disease (Basedow Disease)
01/2014
1
Immune Reconstitution Inflammatory Syndrome
01/2014
1
Opportunistic Infections (Opportunistic Infection)
01/2014
1
Primary Immunodeficiency Diseases
03/2013
1
Urticaria (Hives)
10/2012
1
Arthralgia (Joint Pain)
10/2012
1
Bronchiolitis
10/2012
1
Enterocolitis
10/2012
1
Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
01/2012
1
Common Variable Immunodeficiency
01/2012
1
Exanthema (Rash)
01/2012
1
Disease Progression
01/2011
Drug/Important Bio-Agent (IBA)
8
Immunoglobulin G (IgG)
IBA
11/2021 - 09/2010
5
Antiviral Agents (Antivirals)
IBA
04/2017 - 06/2007
4
Immunoglobulins (Immunoglobulin)
IBA
01/2018 - 08/2008
3
Proteins (Proteins, Gene)
FDA Link
01/2022 - 10/2012
3
Biological Products
IBA
01/2020 - 06/2009
3
Vaccines
IBA
01/2020 - 01/2011
3
Autoantibodies
IBA
01/2020 - 10/2012
3
Antibodies
IBA
11/2019 - 12/2012
3
Immunoglobulin A (IgA)
IBA
11/2015 - 05/2013
3
Interleukin-7 (Interleukin 7)
IBA
06/2009 - 02/2006
2
Monoclonal Antibodies
IBA
04/2022 - 09/2014
2
Neutralizing Antibodies
IBA
03/2022 - 01/2022
2
Transcription Factors (Transcription Factor)
IBA
01/2021 - 01/2019
2
Antigens
IBA
01/2021 - 09/2014
2
Interferons
IBA
01/2021 - 01/2021
2
Membrane Proteins (Integral Membrane Proteins)
IBA
01/2021 - 01/2020
2
Polysaccharides (Glycans)
IBA
01/2018 - 01/2011
2
GP 140
IBA
04/2017 - 07/2014
2
Immunoglobulin Isotypes
IBA
04/2017 - 05/2013
2
Enzymes
IBA
04/2014 - 05/2005
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
10/2004 - 09/2004
1
Peptides (Polypeptides)
IBA
04/2022
1
Autoantigens
IBA
01/2021
1
Fatty Acids (Saturated Fatty Acids)
IBA
01/2021
1
Immunoglobulin D (IgD)
IBA
01/2021
1
Interleukins
IBA
01/2021
1
Interleukin-18 (Interleukin 18)
IBA
01/2020
1
Immunoglobulin M (IgM)
IBA
01/2019
1
L-Selectin
IBA
01/2018
1
Carotenoids (Carotene)
IBA
01/2017
1
Lycopene
IBA
01/2017
1
Bispecific Antibodies
IBA
01/2017
1
Broadly Neutralizing Antibodies
IBA
11/2016
1
Tetanus Toxin
IBA
01/2016
1
Interleukin Receptors (Interleukin Receptor)
IBA
01/2016
1
Hemagglutinins (Hemagglutinin)
IBA
01/2016
1
ibrutinib
IBA
11/2015
1
Proteasome Endopeptidase Complex (Proteasome)
IBA
11/2015
1
Indicators and Reagents (Reagents)
IBA
06/2014
1
glucosidase I
IBA
04/2014
1
Oligosaccharides
IBA
04/2014
1
Interleukin-21 Receptors
IBA
03/2013
1
Antigen-Antibody Complex (Immune Complex)
IBA
11/2012
1
Phospholipases (Phospholipase)
IBA
10/2012
1
Antinuclear Antibodies
IBA
01/2012
1
DNA (Deoxyribonucleic Acid)
IBA
07/2011
1
Sialic Acid Binding Immunoglobulin-like Lectins
IBA
01/2011
Therapy/Procedure
14
Therapeutics
01/2022 - 05/2003
11
Art Therapy
01/2022 - 02/2008
2
Immunotherapy
01/2020 - 10/2017
2
Secondary Prevention
12/2017 - 06/2007
1
Adenoidectomy
03/2022
1
Tonsillectomy
03/2022
1
Aftercare (After-Treatment)
12/2017
1
Drug Therapy (Chemotherapy)
10/2017
1
Splenectomy
01/2015